X 
Company News
Home | Market Info | Company Profile | Company News
Caplin Point Laboratories Ltd.
BSE CODE: 524742   |   NSE CODE: CAPLIPOINT   |   ISIN CODE : INE475E01026   |   09-Jun-2026 Hrs IST
BSE NSE
Rs. 2257.60
147.6 ( 7% )
 
Prev Close ( Rs.)
2110.00
Open ( Rs.)
2124.95
 
High ( Rs.)
2281.00
Low ( Rs.)
2124.95
 
Volume
29424
Week Avg.Volume
11072
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 2255.20
144.2 ( 6.83% )
 
Prev Close ( Rs.)
2111.00
Open ( Rs.)
2122.30
 
High ( Rs.)
2286.00
Low ( Rs.)
2121.30
 
Volume
614724
Week Avg.Volume
257720
 
52 WK High-Low Range(Rs.)
1500.3
2395
15-May-2026 Caplin Point Laboratories’ arm gets USFDA approval for Foscarnet Sodium injection
14-May-2026 Caplin Point Laboratories informs about outcome of board meeting
05-May-2026 Caplin Point’s arm gets USFDA’s approval for Calcium Gluconate Injection
05-May-2026 Caplin Point gains as its arm gets USFDA’s approval for Calcium Gluconate Injection
13-Mar-2026 Caplin Point’s arm gets USFDA’s final nod for Potassium Phosphates Injection
13-Mar-2026 Caplin Point Laboratories informs about press release
02-Mar-2026 Caplin Point’s arm secures USFDA’s final approval for Desmopressin Acetate Injection
24-Feb-2026 Caplin Point Laboratories’ arm gets USFDA’s approval for Sodium Phosphates Injection
24-Feb-2026 Caplin Point Laboratories informs about press release
27-Jan-2026 Caplin Point’s arm gets USFDA’s nod for Methylprednisolone Acetate Injectable Suspension
Page 1 of 3
PREV || NEXT